A previous study showed that the binding of the FZD2 receptor to WNT3A and WNT5A promotes tumor proliferation, migration and invasion through activating the WNT-β-catenin signaling pathway and the β-catenin-independent pathway in neuroblastoma 28. Here, WNT3A is linked to neoplasm.